Junaid Bhutto, MD
Clinical Cardiac Electrophysiology · Scottsdale, AZNPI 1881878536
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 63.4% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $38,432, more than ten times the $2,951 reported in 2019.
Across 938 payments — averaging $89.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$53K
- Biosense Webster, Inc.$18K
- Medtronic$5K
- Medical Device Business Services, Inc.$3K
- Atricure, Inc.$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- plus $3K from 22 others
What the payments were for
- Consulting fees$34,20641%
- Speaking & faculty fees$4,2505%
- Travel & lodging$14,79518%
- Food & beverage$30,70037%
- Education$30%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 313 | $53,230 |
| Biosense Webster, Inc. | 379 | $17,796 |
| Medtronic(2 entities) | 81 | $4,503 |
| Medical Device Business Services, Inc. | 6 | $2,572 |
| Atricure, Inc. | 12 | $1,469 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 45 | $1,199 |
| Boston Scientific | 29 | $1,191 |
| Kestra Medical Technology Services, Inc. | 7 | $280 |
| Bardy Diagnostics, Inc. | 8 | $270 |
| Pfizer | 12 | $201 |
| Cardiva Medical, Inc. | 8 | $180 |
| Acutus Medical, Inc. | 1 | $162 |
| Novartis | 6 | $148 |
| Johnson & Johnson | 9 | $145 |
| Philips North America LLC | 1 | $136 |
| Impulse Dynamics (USA) Inc. | 2 | $130 |
| Sanofi-aventis U.S. LLC | 6 | $93 |
| Cardiofocus, Inc. | 1 | $37 |
| Abiomed | 2 | $36 |
| AstraZeneca | 2 | $33 |
| Terumo Medical Corporation | 1 | $28 |
| Amgen | 1 | $19 |
| Stryker | 1 | $19 |
| Elutia, Inc. | 1 | $18 |
| Baylis Medical Company Inc | 1 | $15 |
| Catheter Precision Inc. | 1 | $15 |
| Chiesi USA, Inc. | 1 | $15 |
| Preventice Services, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$35,856
- ENSITE PRECISION$4,988
- Carto 3$4,572
- Carto 3 System$1,305
- ENSITE$1,253
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$950
- Allure CRT Pacemaker$897
- Micra$858
- Perclose ProStyle$320
- ASSURITY$305
- AFFERA MAPPING SYSTEM$305
- Tendril Pacing Lead$253
- SYNERGY ABLATION SYSTEM$250
- AZURE XT DR MRI SURESCAN$236
- LifeVest$233
- Assure WCD$157
- Carnation Ambulatory Monitor$155
- TactiCath Quartz CFA Catheter$155
- Ensite Cardiac Mapping System$145
- (P84) IGT Devices Systems$136
How this compares
$83,954 in reported general payments places this provider in the 85th percentile of 80 clinical cardiac electrophysiology providers in Arizona.
See all clinical cardiac electrophysiology providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 183 | $149,457 |
| XareltoRivaroxaban | 67 | $67,952 |
| Flecainide Acetate | 123 | $4,854 |
| Dofetilide | 43 | $3,754 |
| SotalolSotalol Hcl | 136 | $2,853 |
| Metoprolol Succinate | 136 | $2,009 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 11 | $1,783 |
| ClopidogrelClopidogrel Bisulfate | 76 | $1,208 |
| Pantoprazole Sodium | 68 | $687 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 21 | $475 |
| Amiodarone Hcl | 24 | $346 |
| Sotalol AfSotalol Hcl | 17 | $298 |
| Carvedilol | 16 | $168 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $60 |
| Lisinopril | 14 | $45 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $201 | $149,457183 claims |
| Johnson & JohnsonXarelto | $145 | $67,95267 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 80 clinical cardiac electrophysiology providers in Arizona.
Other clinical cardiac electrophysiology in Scottsdale
- Ashish SadhuScottsdale$264K
- Thomas MattioniScottsdale$84K
- David RiggioScottsdale$50K
- Rishi CharateScottsdale$31K
- Justin LeeScottsdale$30K
- Ahmad Naeem LoneScottsdale$16K
- Akash MakkarPhoenix$318K
- Jonathan WeissPhoenix$290K
- Yoaav KrauthammerPhoenix$238K
- Vijendra SwarupPhoenix$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.